mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.7 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |